Moussa B. H. Youdim

46.9k total citations · 5 hit papers
553 papers, 37.1k citations indexed

About

Moussa B. H. Youdim is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Moussa B. H. Youdim has authored 553 papers receiving a total of 37.1k indexed citations (citations by other indexed papers that have themselves been cited), including 212 papers in Neurology, 186 papers in Cellular and Molecular Neuroscience and 158 papers in Molecular Biology. Recurrent topics in Moussa B. H. Youdim's work include Parkinson's Disease Mechanisms and Treatments (197 papers), Cholinesterase and Neurodegenerative Diseases (92 papers) and Alzheimer's disease research and treatments (91 papers). Moussa B. H. Youdim is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (197 papers), Cholinesterase and Neurodegenerative Diseases (92 papers) and Alzheimer's disease research and treatments (91 papers). Moussa B. H. Youdim collaborates with scholars based in Israel, United States and Germany. Moussa B. H. Youdim's co-authors include Silvia Mandel, Tamar Amit, Peter Riederer, Orly Weinreb, Dorit Ben‐Shachar, Orit Bar‐Am, Keith F. Tipton, J. P. M. Finberg, Hailin Zheng and Mati Fridkin and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Moussa B. H. Youdim

552 papers receiving 36.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Iron, brain ageing and neurodegenerative disorders

2004 1.5k citations Moussa B. H. Youdim, Peter Riederer et al. profile →
Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1989 1.1k citations Peter Riederer, Moussa B. H. Youdim et al. Journal of Neurochemistry profile →
The therapeutic potential of monoamine oxidase inhibitors

2006 1.1k citations Moussa B. H. Youdim et al. profile →
Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?

1994 591 citations Dorit Ben‐Shachar, Peter Riederer et al. Journal of Neurochemistry profile →
Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness

2006 518 citations Moussa B. H. Youdim et al. British Journal of Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Moussa B. H. Youdim Israel	102	12.4k	10.2k	10.0k	7.6k	6.3k	553	37.1k
Peter Riederer Germany	91	11.0k 0.9×	12.2k 1.2×	9.8k 1.0×	7.6k 1.0×	3.1k 0.5×	534	35.4k
M. Flint Beal United States	98	9.5k 0.8×	9.0k 0.9×	19.5k 2.0×	10.2k 1.3×	2.7k 0.4×	221	36.5k
William R. Markesbery United States	114	5.1k 0.4×	5.8k 0.6×	17.0k 1.7×	22.1k 2.9×	4.9k 0.8×	404	49.9k
Mark A. Smith United States	134	4.7k 0.4×	9.8k 1.0×	23.8k 2.4×	28.5k 3.7×	8.4k 1.3×	733	61.9k
Peter Jenner United Kingdom	81	15.2k 1.2×	12.5k 1.2×	9.3k 0.9×	4.2k 0.6×	1.9k 0.3×	463	31.0k
Patrick L. McGeer Canada	106	8.6k 0.7×	13.8k 1.4×	12.6k 1.3×	15.2k 2.0×	4.4k 0.7×	492	42.7k
Harry Ischiropoulos United States	87	6.4k 0.5×	4.9k 0.5×	13.0k 1.3×	14.4k 1.9×	1.2k 0.2×	214	37.8k
George Perry United States	134	7.0k 0.6×	9.3k 0.9×	29.0k 2.9×	36.7k 4.8×	10.1k 1.6×	905	69.0k
Serge Przedborski United States	110	21.8k 1.8×	15.3k 1.5×	14.3k 1.4×	7.8k 1.0×	2.3k 0.4×	261	41.6k
Edith G. McGeer Canada	92	7.7k 0.6×	14.3k 1.4×	10.3k 1.0×	10.3k 1.4×	3.2k 0.5×	393	34.8k

Countries citing papers authored by Moussa B. H. Youdim

Since Specialization

Citations

This map shows the geographic impact of Moussa B. H. Youdim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moussa B. H. Youdim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moussa B. H. Youdim more than expected).

Fields of papers citing papers by Moussa B. H. Youdim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moussa B. H. Youdim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moussa B. H. Youdim. The network helps show where Moussa B. H. Youdim may publish in the future.

Co-authorship network of co-authors of Moussa B. H. Youdim

This figure shows the co-authorship network connecting the top 25 collaborators of Moussa B. H. Youdim. A scholar is included among the top collaborators of Moussa B. H. Youdim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moussa B. H. Youdim. Moussa B. H. Youdim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Wei, et al.. (2016). Anti-inflammatory and protective effects of MT-031, a novel multitarget MAO-A and AChE/BuChE inhibitor in scopolamine mouse model and inflammatory cells. Neuropharmacology. 113(Pt A). 445–456. 28 indexed citations

Молочников, Л. С., Jose M. Rabey, Ubaldo Bonuccelli, et al.. (2012). A molecular signature in blood identifies early Parkinson’s disease. Molecular Neurodegeneration. 7(1). 26–26. 97 indexed citations

Sian‐Hülsmann, Jeswinder, Silvia Mandel, Moussa B. H. Youdim, & Peter Riederer. (2010). The relevance of iron in the pathogenesis of Parkinson’s disease. Journal of Neurochemistry. 118(6). 939–957. 284 indexed citations

Johnson, Shakevia, Deyin Lu, Moussa B. H. Youdim, et al.. (2010). The New Inhibitor of Monoamine Oxidase, M30, has a Neuroprotective Effect Against Dexamethasone-Induced Brain Cell Apoptosis. Frontiers in Neuroscience. 4. 180–180. 26 indexed citations

Stockmeier, Craig A., Herbert Y. Meltzer, James C. Overholser, et al.. (2009). A Novel Role for Glyceraldehyde-3-Phosphate Dehydrogenase and Monoamine Oxidase B Cascade in Ethanol-Induced Cellular Damage. Biological Psychiatry. 67(9). 855–863. 51 indexed citations

Youdim, Moussa B. H., Merav Yogev‐Falach, Orly Weinreb, et al.. (2004). Rasagiline: Neurodegeneration, neuroprotection, and mitochondrial permeability transition. Journal of Neuroscience Research. 79(1-2). 172–179. 139 indexed citations

Amit, Tamar, et al.. (2002). Non-steroidal Anti-inflammatory Drugs Stimulate Secretion of Non-amyloidogenic Precursor Protein. Journal of Biological Chemistry. 277(35). 31466–31473. 73 indexed citations

Sterling, Jeffrey, et al.. (1998). (R)(+)-N-Propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase B. Journal of neural transmission. Supplementum. 52. 301–305. 53 indexed citations

Youdim, Moussa B. H. & Peter Riederer. (1997). Understanding Parkinson's Disease. Scientific American. 276(1). 52–59. 111 indexed citations

10.

Finberg, J. P. M., Itschak Lamensdorf, John W. Commissiong, & Moussa B. H. Youdim. (1996). Pharmacology and neuroprotective properties of rasagiline. PubMed. 48. 95–101. 76 indexed citations

11.

Leenders, Klaus L., Angelo Antonini, Peter Smith‐Jones, et al.. (1994). Blood to brain iron uptake in one rhesus monkey using [Fe-52]-citrate and positron emission tomography (PET): influence of haloperidol.. PubMed. 43. 123–32. 11 indexed citations

12.

Goldberg, Steven R., Sevil Yaşar, Jack Bergman, & Moussa B. H. Youdim. (1994). Introduction: Examination of clinical and preclinical pharmacologic data relating to abuse liability of l-deprenyl (selegiline)*. Clinical Pharmacology & Therapeutics. 56(6 Pt 2). 721–724. 4 indexed citations

13.

Hochberg, Ze’ev, Pnina Hertz, Sophia Ish‐Shalom, et al.. (1992). The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa. Metabolism. 41(1). 106–112. 148 indexed citations

14.

Youdim, Moussa B. H. & J. P. M. Finberg. (1991). New directions in monoamine oxidase A and B selective inhibitors and substrates. Biochemical Pharmacology. 41(2). 155–162. 120 indexed citations

15.

Ben‐Shachar, Dorit, Shlomo Yehuda, J. P. M. Finberg, Ilana Spanier, & Moussa B. H. Youdim. (1988). Selective Alteration in Blood‐Brain Barrier and Insulin Transport in Iron‐Deficient Rats. Journal of Neurochemistry. 50(5). 1434–1437. 28 indexed citations

16.

Mendlewicz, Julien & Moussa B. H. Youdim. (1983). A double-blind placebo study of L-deprenyl in affective disorders. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 19(3). 328–332. 1 indexed citations

17.

Salach, James I., Kristina Detmer, & Moussa B. H. Youdim. (1979). The Reaction of Bovine and Rat Liver Monoamine Oxidase with [14C]-Clorgyline and [14C]-Deprenyl. Molecular Pharmacology. 16(1). 234–241. 61 indexed citations

18.

Woods, H. F., Moussa B. H. Youdim, D J Boullin, & Sheila T. Callender. (1977). Monoamine Metabolism and Platelet Function in Iron‐Deficiency Anaemia. Novartis Foundation symposium. 227–248. 24 indexed citations

19.

Agid, Yves, F. Javoy, & Moussa B. H. Youdim. (1973). Monoamine oxidase and aldehyde dehydrogenase activity in the striatum of rats after 6‐hydroxydopamine lesion of the nigrostriatal pathway. British Journal of Pharmacology. 48(1). 175–178. 54 indexed citations

20.

Sandler, M. & Moussa B. H. Youdim. (1968). The effect of tyramine, reserpine and other drugs on catecholamine metabolism in man.. PubMed Central. 34(1). 224P–225P. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact